A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides

J Infect Dis. 1996 Jan;173(1):113-8. doi: 10.1093/infdis/173.1.113.

Abstract

In an attempt to develop an assay specific for antibody to capsular polysaccharide (PS) of Streptococcus pneumoniae, the ability of ELISA and Farr (radioactive antigen-binding) assay for antibodies to 6B and 19A PS to be affected by antibodies to C-polysaccharide (C-PS) was compared. Preabsorption with C-PS reduced values obtained by ELISA for anti-6B antibody by > 3-fold in 5 of 10 preimmune and 7 of 26 postimmune sera. In contrast, absorption reduced values by > 3-fold in 0 of 36 samples studied with the Farr assay. Similar results were observed when the absorption was done with CSR-SCS2 S. pneumoniae. Furthermore, when anti-19A antibody levels were examined, preabsorption with R36a S. pneumoniae reduced ELISA values by 3-fold in 7 of 22 samples, whereas no samples had 3-fold reduction by Farr assay. Thus, the Farr assay for capsular PS is less affected than the ELISA by anti-C-PS antibody.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Bacterial / analysis*
  • Bacterial Capsules / immunology*
  • Bacterial Vaccines / immunology
  • Enzyme-Linked Immunosorbent Assay / methods*
  • Humans
  • Immunization
  • Pneumococcal Infections / immunology
  • Pneumococcal Vaccines
  • Polysaccharides, Bacterial / immunology*
  • Radioimmunoprecipitation Assay / methods*
  • Sensitivity and Specificity
  • Streptococcus pneumoniae / immunology*

Substances

  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Pneumococcal Vaccines
  • Polysaccharides, Bacterial